首页 > 最新文献

Archives of biochemistry and biophysics最新文献

英文 中文
Photorin controls the intracellular activation and bacteriotoxic effect of Photorhabdus laumondii protease S during its expression in Escherichia coli Photorin在大肠杆菌中表达过程中控制laumondii光habdus蛋白酶S的胞内活化和细菌毒性作用
IF 3 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-11-13 DOI: 10.1016/j.abb.2025.110672
Anastasia O. Svetlova , Alexey A. Komissarov , Maria A. Karaseva , Ksenia N. Chukhontseva , Olga V. Pobeguts , Mariya A. Galyamina , Igor P. Smirnov , Polina D. Kuchur , Anna O. Izotova , Stepan V. Toshchakov , Ilya V. Demidyuk
An important role in the regulation of protease activity in living systems is played by their propeptides and endogenous protein inhibitors. Both are capable of repressing enzyme activity, ensuring it occurs only at the right time and/or in the right place. Therefore, propeptides and inhibitors may appear to perform the same function. However, many proteases have both, but the interplay between these two modes of regulation remains virtually unexplored. We investigated the role of the propeptide of Photorhabdus laumondii protealysin-like protease S (PrtS) and its emfourin-like inhibitor (ELI), photorin, in controlling intracellular enzyme activation in an Escherichia coli model. In the absence of the inhibitor, PrtS was found to be activated within cells due to autocatalytic cleavage of the propeptide, which led to the death of most bacteria. Along with this, a bacterial population emerges in which PrtS gene transcription is suppressed apparently due to the action of epigenetic mechanisms. Thus, the propeptide alone is unable to suppress aberrant intracellular activity of PrtS, whereas photorin protects cells from the toxic effect of PrtS and prevents inactivation of its gene. In summary, using PrtS as an example, we demonstrated for the first time that protealysin-like proteases (PLPs) which are ubiquitous in bacteria and are probably involved in pathogenesis, are toxic to bacteria. In this context, the function of ELIs, whose genes in bacterial genomes are co-localized with those of PLPs, is to protect bacteria from aberrant intracellular activity of PLPs.
蛋白酶的前肽和内源性蛋白抑制剂在生物系统中发挥着重要的调节作用。两者都能够抑制酶的活性,确保它只在正确的时间和/或在正确的地方发生。因此,前肽和抑制剂似乎具有相同的功能。然而,许多蛋白酶两者都有,但这两种调节模式之间的相互作用实际上尚未被探索。在大肠杆菌模型中,研究了laumondii光habdus protealysin样蛋白酶S (PrtS)前肽及其emfourin样抑制剂(ELI) photorin在控制胞内酶激活中的作用。在缺乏抑制剂的情况下,由于前肽的自催化裂解,PrtS被发现在细胞内被激活,导致大多数细菌死亡。与此同时,出现了一种由于表观遗传机制的作用而明显抑制PrtS基因转录的细菌群体。因此,单独的前肽无法抑制PrtS的细胞内异常活性,而光素可以保护细胞免受PrtS的毒性作用,并防止其基因失活。总之,以PrtS为例,我们首次证明了在细菌中普遍存在并可能参与致病机制的蛋白溶素样蛋白酶(PLPs)对细菌具有毒性。在这种情况下,细菌基因组中的ELIs基因与PLPs基因共定位,其功能是保护细菌免受PLPs细胞内异常活性的影响。
{"title":"Photorin controls the intracellular activation and bacteriotoxic effect of Photorhabdus laumondii protease S during its expression in Escherichia coli","authors":"Anastasia O. Svetlova ,&nbsp;Alexey A. Komissarov ,&nbsp;Maria A. Karaseva ,&nbsp;Ksenia N. Chukhontseva ,&nbsp;Olga V. Pobeguts ,&nbsp;Mariya A. Galyamina ,&nbsp;Igor P. Smirnov ,&nbsp;Polina D. Kuchur ,&nbsp;Anna O. Izotova ,&nbsp;Stepan V. Toshchakov ,&nbsp;Ilya V. Demidyuk","doi":"10.1016/j.abb.2025.110672","DOIUrl":"10.1016/j.abb.2025.110672","url":null,"abstract":"<div><div>An important role in the regulation of protease activity in living systems is played by their propeptides and endogenous protein inhibitors. Both are capable of repressing enzyme activity, ensuring it occurs only at the right time and/or in the right place. Therefore, propeptides and inhibitors may appear to perform the same function. However, many proteases have both, but the interplay between these two modes of regulation remains virtually unexplored. We investigated the role of the propeptide of <em>Photorhabdus laumondii</em> protealysin-like protease S (PrtS) and its emfourin-like inhibitor (ELI), photorin, in controlling intracellular enzyme activation in an <em>Escherichia coli</em> model. In the absence of the inhibitor, PrtS was found to be activated within cells due to autocatalytic cleavage of the propeptide, which led to the death of most bacteria. Along with this, a bacterial population emerges in which PrtS gene transcription is suppressed apparently due to the action of epigenetic mechanisms. Thus, the propeptide alone is unable to suppress aberrant intracellular activity of PrtS, whereas photorin protects cells from the toxic effect of PrtS and prevents inactivation of its gene. In summary, using PrtS as an example, we demonstrated for the first time that protealysin-like proteases (PLPs) which are ubiquitous in bacteria and are probably involved in pathogenesis, are toxic to bacteria. In this context, the function of ELIs, whose genes in bacterial genomes are co-localized with those of PLPs, is to protect bacteria from aberrant intracellular activity of PLPs.</div></div>","PeriodicalId":8174,"journal":{"name":"Archives of biochemistry and biophysics","volume":"775 ","pages":"Article 110672"},"PeriodicalIF":3.0,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145526749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hirudin promotes peripheral nerve repair and alleviates pain by regulating the EGFR-PI3K/AKT/mTOR pathway 水蛭素通过调节EGFR-PI3K/AKT/mTOR通路促进周围神经修复,减轻疼痛。
IF 3 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-11-10 DOI: 10.1016/j.abb.2025.110671
Long Wu , Zhe Zhang , Dongbo Tian , Kaiye Chen , Jing-hao Liang , Heng Yu , Ke Wang , Kongbin Chen , Yifan Wu , Hede Yan

Purpose

Peripheral nerve injury (PNI) often results in severe neuropathic pain and impaired nerve regeneration. Hirudin, derived from the traditional Chinese medicinal leech, has not yet been investigated for its therapeutic potential in the treatment of PNI.

Methods

A total of 144 male Sprague-Dawley rats were subjected to a sciatic nerve crush injury model. Rats were grouped into 5 cohorts: sham, control, PNI + Hirudin (10 mg/kg), PNI + Hirudin (15 mg/kg), and PNI + Hirudin (15 mg/kg) + NSC228155. There were various assessments conducted, including histological staining, immunofluorescence, transmission electron microscopy (TEM), behavioral tests, and Western blot analyses.

Results

Our experiments demonstrated that Hirudin significantly improved the structural integrity of regenerating nerves, enhanced orderly axonal regeneration and remyelination. It also alleviated neuropathic pain, as evidenced by reduced autotomy scores and decreased expression of pain-related markers (Iba-1, C-Fos, and substance P). Mechanistic studies revealed that Hirudin downregulated the activation of the EGFR-dependent PI3K/AKT/mTOR signaling pathway, which contributed to its therapeutic effects.

Conclusion

Hirudin can effectively enhance peripheral nerve regeneration and alleviate neuropathic pain following PNI. These findings suggest that Hirudin holds promise as a therapeutic agent for the treatment of PNI-induced neuropathic pain and impaired nerve regeneration.
目的:周围神经损伤(PNI)常导致严重的神经性疼痛和神经再生受损。水蛭素来源于中药水蛭,目前尚未对其治疗PNI的潜力进行研究。方法:采用144只雄性sd大鼠建立坐骨神经挤压损伤模型。将大鼠分为5组:假手术组、对照组、PNI +水蛭素(10 mg/kg)、PNI +水蛭素(15 mg/kg)、PNI +水蛭素(15 mg/kg) + NSC228155。进行了各种评估,包括组织学染色,免疫荧光,透射电子显微镜(TEM),行为测试和western blot分析。结果:水蛭素能明显改善再生神经的结构完整性,促进轴突有序再生和髓鞘再生。自体切开术评分降低,疼痛相关标记物(Iba-1、C-Fos和P物质)表达降低,也可以缓解神经性疼痛。机制研究显示水蛭素下调egfr依赖性PI3K/AKT/mTOR信号通路的激活,这有助于其治疗效果。结论:水蛭素能有效促进周围神经再生,减轻PNI术后神经性疼痛。这些发现表明水蛭素有望作为治疗pni诱导的神经性疼痛和神经再生受损的治疗剂。
{"title":"Hirudin promotes peripheral nerve repair and alleviates pain by regulating the EGFR-PI3K/AKT/mTOR pathway","authors":"Long Wu ,&nbsp;Zhe Zhang ,&nbsp;Dongbo Tian ,&nbsp;Kaiye Chen ,&nbsp;Jing-hao Liang ,&nbsp;Heng Yu ,&nbsp;Ke Wang ,&nbsp;Kongbin Chen ,&nbsp;Yifan Wu ,&nbsp;Hede Yan","doi":"10.1016/j.abb.2025.110671","DOIUrl":"10.1016/j.abb.2025.110671","url":null,"abstract":"<div><h3>Purpose</h3><div>Peripheral nerve injury (PNI) often results in severe neuropathic pain and impaired nerve regeneration. Hirudin, derived from the traditional Chinese medicinal leech, has not yet been investigated for its therapeutic potential in the treatment of PNI.</div></div><div><h3>Methods</h3><div>A total of 144 male Sprague-Dawley rats were subjected to a sciatic nerve crush injury model. Rats were grouped into 5 cohorts: sham, control, PNI + Hirudin (10 mg/kg), PNI + Hirudin (15 mg/kg), and PNI + Hirudin (15 mg/kg) + NSC228155. There were various assessments conducted, including histological staining, immunofluorescence, transmission electron microscopy (TEM), behavioral tests, and Western blot analyses.</div></div><div><h3>Results</h3><div>Our experiments demonstrated that Hirudin significantly improved the structural integrity of regenerating nerves, enhanced orderly axonal regeneration and remyelination. It also alleviated neuropathic pain, as evidenced by reduced autotomy scores and decreased expression of pain-related markers (Iba-1, C-Fos, and substance P). Mechanistic studies revealed that Hirudin downregulated the activation of the EGFR-dependent PI3K/AKT/mTOR signaling pathway, which contributed to its therapeutic effects.</div></div><div><h3>Conclusion</h3><div>Hirudin can effectively enhance peripheral nerve regeneration and alleviate neuropathic pain following PNI. These findings suggest that Hirudin holds promise as a therapeutic agent for the treatment of PNI-induced neuropathic pain and impaired nerve regeneration.</div></div>","PeriodicalId":8174,"journal":{"name":"Archives of biochemistry and biophysics","volume":"775 ","pages":"Article 110671"},"PeriodicalIF":3.0,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145501538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aerobic exercise intervention improves angiotensin Ⅱ-induced cardiac remodeling by inhibiting RBP4-STRA6-Wnt/β-catenin pathway 有氧运动干预通过抑制RBP4-STRA6-Wnt/β-catenin通路改善血管紧张素Ⅱ诱导的心脏重构。
IF 3 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-11-06 DOI: 10.1016/j.abb.2025.110670
Jiayu Yao , Jinyun Wang , Shuo Lin , Guangyuan Sha , Shen Wang , Mengyun Yang , Zaoshang Chang , Jingbo Xia , Min Hu
Most cardiovascular diseases are accompanied by cardiac remodeling, but physical exercise can mitigate and decelerate this process. Retinol-binding protein 4 (RBP4) has been associated with cardiovascular disease in both basic research and clinical settings. Therefore, the present study aimed to investigate the mechanism underlying RBP4 in exercise ameliorating cardiac remodeling. Our findings indicate that mice model of angiotensin Ⅱ (Ang Ⅱ)-induced cardiac hypertrophy exhibited elevated blood pressure, impaired cardiac function, increased myocardial fibrosis, and mitochondrial degradation, alongside elevated RBP4 levels in myocardial tissue. A 9-week aerobic exercise regimen improved these indexes and decreased RBP4 expression. The cell surface receptor stimulated by retinoic acid 6 (STRA6), which serves as a membrane receptor for RBP4, is implicated in the activation of the Wnt/β-catenin signaling pathway, with its knockdown potentially inhibiting this pathway. Our subsequent analyses identified a significant upregulation of the STRA6 protein in myocardial tissue of the mice model of cardiac hypertrophy. Further investigations showed that total β-catenin levels remained unchanged, there was an increase in nuclear β-catenin, which enhanced the expression of matrix metalloproteinase 7 (MMP7) and cyclooxygenase 2 (COX2). These alterations were reversed following exercise intervention. The results suggest that RBP4 enhances STRA6 expression in cardiac hypertrophy mice hearts and facilitates β-catenin nuclear translocation and transcriptional activity, leading to elevated levels of MMP7 and COX2 expression. Aerobic exercise appears to attenuate the myocardial inflammatory response by reducing RBP4 expression and inhibiting the Wnt/β-catenin pathway, thereby ameliorating Ang Ⅱ-induced cardiac remodeling.
大多数心血管疾病都伴有心脏重构,但体育锻炼可以减轻和减缓这一过程。视黄醇结合蛋白4 (RBP4)在基础研究和临床环境中都与心血管疾病有关。因此,本研究旨在探讨RBP4在运动改善心脏重构中的作用机制。我们的研究结果表明,血管紧张素Ⅱ(AngⅡ)诱导的心脏肥厚小鼠模型表现出血压升高、心功能受损、心肌纤维化增加和线粒体降解,同时心肌组织中RBP4水平升高。为期9周的有氧运动方案改善了这些指标并降低了RBP4的表达。视黄酸6 (STRA6)刺激的细胞表面受体,作为RBP4的膜受体,与Wnt/β-catenin信号通路的激活有关,其敲低可能抑制该通路。我们随后的分析发现,心肌肥厚模型小鼠心肌组织中STRA6蛋白显著上调。进一步研究发现,β-catenin总水平不变,细胞核β-catenin增加,从而增强了基质金属蛋白酶7 (MMP7)和环氧合酶2 (COX2)的表达。这些改变在运动干预后被逆转。结果表明,RBP4增强STRA6在心肌肥厚小鼠心脏中的表达,促进β-catenin核易位和转录活性,导致MMP7和COX2表达水平升高。有氧运动似乎通过降低RBP4表达和抑制Wnt/β-catenin通路来减轻心肌炎症反应,从而改善AngⅡ诱导的心脏重构。
{"title":"Aerobic exercise intervention improves angiotensin Ⅱ-induced cardiac remodeling by inhibiting RBP4-STRA6-Wnt/β-catenin pathway","authors":"Jiayu Yao ,&nbsp;Jinyun Wang ,&nbsp;Shuo Lin ,&nbsp;Guangyuan Sha ,&nbsp;Shen Wang ,&nbsp;Mengyun Yang ,&nbsp;Zaoshang Chang ,&nbsp;Jingbo Xia ,&nbsp;Min Hu","doi":"10.1016/j.abb.2025.110670","DOIUrl":"10.1016/j.abb.2025.110670","url":null,"abstract":"<div><div>Most cardiovascular diseases are accompanied by cardiac remodeling, but physical exercise can mitigate and decelerate this process. Retinol-binding protein 4 (RBP4) has been associated with cardiovascular disease in both basic research and clinical settings. Therefore, the present study aimed to investigate the mechanism underlying RBP4 in exercise ameliorating cardiac remodeling. Our findings indicate that mice model of angiotensin Ⅱ (Ang Ⅱ)-induced cardiac hypertrophy exhibited elevated blood pressure, impaired cardiac function, increased myocardial fibrosis, and mitochondrial degradation, alongside elevated RBP4 levels in myocardial tissue. A 9-week aerobic exercise regimen improved these indexes and decreased RBP4 expression. The cell surface receptor stimulated by retinoic acid 6 (STRA6), which serves as a membrane receptor for RBP4, is implicated in the activation of the Wnt/β-catenin signaling pathway, with its knockdown potentially inhibiting this pathway. Our subsequent analyses identified a significant upregulation of the STRA6 protein in myocardial tissue of the mice model of cardiac hypertrophy. Further investigations showed that total β-catenin levels remained unchanged, there was an increase in nuclear β-catenin, which enhanced the expression of matrix metalloproteinase 7 (MMP7) and cyclooxygenase 2 (COX2). These alterations were reversed following exercise intervention. The results suggest that RBP4 enhances STRA6 expression in cardiac hypertrophy mice hearts and facilitates β-catenin nuclear translocation and transcriptional activity, leading to elevated levels of MMP7 and COX2 expression. Aerobic exercise appears to attenuate the myocardial inflammatory response by reducing RBP4 expression and inhibiting the Wnt/β-catenin pathway, thereby ameliorating Ang Ⅱ-induced cardiac remodeling.</div></div>","PeriodicalId":8174,"journal":{"name":"Archives of biochemistry and biophysics","volume":"775 ","pages":"Article 110670"},"PeriodicalIF":3.0,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145476575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BACH1 drives ferroptosis in lung ischemia-reperfusion injury through epigenetic suppression of STAT3-Mediated antioxidant defense 通过表观遗传抑制stat3介导的抗氧化防御,BACH1驱动肺缺血再灌注损伤中的铁凋亡。
IF 3 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-11-03 DOI: 10.1016/j.abb.2025.110669
Ying Gu , Xiuli Liu , Xiaojun Zhang , Ning Zhang

Background

Lung ischemia-reperfusion injury (LIRI) is a major complication in lung transplantation, with ferroptosis as a key mechanism. The role of BACH1, a regulator of oxidative stress and iron metabolism, in LIRI-associated ferroptosis is unclear. This study explores whether BACH1 promotes LIRI via ferroptosis-related pathways.

Methods

The GSE9634 dataset was analyzed to identify BACH1-regulated networks in LIRI. MLE-12 alveolar epithelial cells underwent hypoxia-reoxygenation with BACH1 overexpression or knockdown, with or without PU.1/SHP1 inhibitors. Protein expression was evaluated by Western blot and immunofluorescence, and oxidative stress markers (MDA, ROS) and antioxidant enzyme activity (SOD) by ELISA. A rat LIRI model with lentiviral BACH1 modulation was used for in vivo validation, assessed via histopathology, TUNEL staining, and immunohistochemistry.

Results

BACH1 positively correlated with KDM4C and PU.1 but negatively with STAT3. BACH1 overexpression upregulated KDM4C, reduced H3K9me3 methylation, and activated PU.1, promoting SHP1-mediated STAT3 dephosphorylation. This suppressed antioxidant proteins (GPX4, SLC7A11, FTH1), increasing ferroptosis. PU.1/SHP1 inhibition restored STAT3 phosphorylation and antioxidant expression, reducing oxidative damage. In vivo, BACH1 overexpression worsened lung injury and apoptosis, while knockdown was protective. Immunohistochemistry showed BACH1 upregulation reduced phospho-STAT3 and SLC7A11 in injured tissue.

Conclusion

BACH1 drives ferroptosis-mediated LIRI via a KDM4C/PU.1/SHP1 axis, suppressing the STAT3/GPX4/SLC7A11/FTH1 pathway. Targeting BACH1 or its effectors offers therapeutic potential for LIRI prevention.
背景:肺缺血再灌注损伤(LIRI)是肺移植的主要并发症,铁下垂是其重要机制。作为氧化应激和铁代谢的调节因子,BACH1在lii相关铁下垂中的作用尚不清楚。本研究探讨BACH1是否通过凋亡相关途径促进LIRI。方法:分析GSE9634数据集,确定bach1调控的LIRI网络。使用或不使用PU.1/SHP1抑制剂时,MLE-12肺泡上皮细胞缺氧再氧化,BACH1过表达或敲低。Western blot和免疫荧光法检测蛋白表达,ELISA法检测氧化应激标志物(MDA、ROS)和抗氧化酶活性(SOD)。采用慢病毒BACH1调节的大鼠LIRI模型进行体内验证,通过组织病理学、TUNEL染色和免疫组织化学进行评估。结果:BACH1与KDM4C、PU.1呈正相关,与STAT3负相关。BACH1过表达上调KDM4C,降低H3K9me3甲基化,激活PU.1,促进shp1介导的STAT3去磷酸化。这抑制了抗氧化蛋白(GPX4, SLC7A11, FTH1),增加了铁下垂。PU.1/SHP1抑制恢复STAT3磷酸化和抗氧化表达,减轻氧化损伤。在体内,BACH1过表达加重了肺损伤和细胞凋亡,而低表达则具有保护作用。免疫组化显示BACH1上调可降低损伤组织中磷酸化stat3和SLC7A11。结论:BACH1通过KDM4C/PU驱动铁凋亡介导的LIRI。抑制STAT3/GPX4/SLC7A11/FTH1通路。靶向BACH1或其效应物为预防LIRI提供了治疗潜力。
{"title":"BACH1 drives ferroptosis in lung ischemia-reperfusion injury through epigenetic suppression of STAT3-Mediated antioxidant defense","authors":"Ying Gu ,&nbsp;Xiuli Liu ,&nbsp;Xiaojun Zhang ,&nbsp;Ning Zhang","doi":"10.1016/j.abb.2025.110669","DOIUrl":"10.1016/j.abb.2025.110669","url":null,"abstract":"<div><h3>Background</h3><div>Lung ischemia-reperfusion injury (LIRI) is a major complication in lung transplantation, with ferroptosis as a key mechanism. The role of BACH1, a regulator of oxidative stress and iron metabolism, in LIRI-associated ferroptosis is unclear. This study explores whether BACH1 promotes LIRI via ferroptosis-related pathways.</div></div><div><h3>Methods</h3><div>The GSE9634 dataset was analyzed to identify BACH1-regulated networks in LIRI. MLE-12 alveolar epithelial cells underwent hypoxia-reoxygenation with BACH1 overexpression or knockdown, with or without PU.1/SHP1 inhibitors. Protein expression was evaluated by Western blot and immunofluorescence, and oxidative stress markers (MDA, ROS) and antioxidant enzyme activity (SOD) by ELISA. A rat LIRI model with lentiviral BACH1 modulation was used for in vivo validation, assessed via histopathology, TUNEL staining, and immunohistochemistry.</div></div><div><h3>Results</h3><div>BACH1 positively correlated with KDM4C and PU.1 but negatively with STAT3. BACH1 overexpression upregulated KDM4C, reduced H3K9me3 methylation, and activated PU.1, promoting SHP1-mediated STAT3 dephosphorylation. This suppressed antioxidant proteins (GPX4, SLC7A11, FTH1), increasing ferroptosis. PU.1/SHP1 inhibition restored STAT3 phosphorylation and antioxidant expression, reducing oxidative damage. In vivo, BACH1 overexpression worsened lung injury and apoptosis, while knockdown was protective. Immunohistochemistry showed BACH1 upregulation reduced phospho-STAT3 and SLC7A11 in injured tissue.</div></div><div><h3>Conclusion</h3><div>BACH1 drives ferroptosis-mediated LIRI via a KDM4C/PU.1/SHP1 axis, suppressing the STAT3/GPX4/SLC7A11/FTH1 pathway. Targeting BACH1 or its effectors offers therapeutic potential for LIRI prevention.</div></div>","PeriodicalId":8174,"journal":{"name":"Archives of biochemistry and biophysics","volume":"775 ","pages":"Article 110669"},"PeriodicalIF":3.0,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145450684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emergence and characterization of lipidated β-lactamases 脂化β-内酰胺酶的出现和特性。
IF 3 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-11-03 DOI: 10.1016/j.abb.2025.110644
Thomas Smisek , Walter Fast , Christian P. Whitman
Since the discovery of penicillin, β-lactam antibiotics have been a mainstay for the treatment of bacterial infections. Resistance to β-lactam antibiotics via β-lactamase enzymes was identified before β-lactams even reached a clinical setting, and decades of use has only increased the risk posed by β-lactam resistance, largely driven by β-lactamase enzymes. While most β-lactamases are soluble periplasmic enzymes, a minority are membrane anchored lipoproteins. With the emergence and proliferation of the highly potent New Delhi metallo-β-lactamase (NDM) in the late 2000's, lipidated β-lactamases have catapulted from little more than biochemical curiosities, to key features of one of the most potent and prevalent antibiotic resistance enzymes. NDM is the most well-known lipidated β-lactamase. However, recent work highlights both emerging lipidated β-lactamases as well as the fact that lipidation may be more common in previously characterized β-lactamases than thought.
自从发现青霉素以来,β-内酰胺类抗生素一直是治疗细菌感染的主要药物。通过β-内酰胺酶对β-内酰胺类抗生素的耐药性在β-内酰胺类抗生素进入临床之前就已被发现,几十年的使用只会增加β-内酰胺类抗生素耐药的风险,这主要是由β-内酰胺酶驱动的。虽然大多数β-内酰胺酶是可溶性质周酶,但少数是膜锚定脂蛋白。随着高效的新德里金属β-内酰胺酶(NDM)在2000年代后期的出现和扩散,脂化β-内酰胺酶已经从仅仅是生物化学上的好奇心,一跃成为最有效和最普遍的抗生素抗性酶之一的关键特征。NDM是最著名的脂化β-内酰胺酶。然而,最近的工作强调了新兴的脂化β-内酰胺酶,以及脂化在以前表征的β-内酰胺酶中可能比想象的更常见的事实。
{"title":"Emergence and characterization of lipidated β-lactamases","authors":"Thomas Smisek ,&nbsp;Walter Fast ,&nbsp;Christian P. Whitman","doi":"10.1016/j.abb.2025.110644","DOIUrl":"10.1016/j.abb.2025.110644","url":null,"abstract":"<div><div>Since the discovery of penicillin, β-lactam antibiotics have been a mainstay for the treatment of bacterial infections. Resistance to β-lactam antibiotics via β-lactamase enzymes was identified before β-lactams even reached a clinical setting, and decades of use has only increased the risk posed by β-lactam resistance, largely driven by β-lactamase enzymes. While most β-lactamases are soluble periplasmic enzymes, a minority are membrane anchored lipoproteins. With the emergence and proliferation of the highly potent New Delhi metallo-β-lactamase (NDM) in the late 2000's, lipidated β-lactamases have catapulted from little more than biochemical curiosities, to key features of one of the most potent and prevalent antibiotic resistance enzymes. NDM is the most well-known lipidated β-lactamase. However, recent work highlights both emerging lipidated β-lactamases as well as the fact that lipidation may be more common in previously characterized β-lactamases than thought.</div></div>","PeriodicalId":8174,"journal":{"name":"Archives of biochemistry and biophysics","volume":"775 ","pages":"Article 110644"},"PeriodicalIF":3.0,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145450702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Substrate stiffness attenuates cardiomyocyte depolarization slope via sodium channel kinetics modulation 基底硬度通过钠通道动力学调节减弱心肌细胞去极化斜率。
IF 3 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-10-31 DOI: 10.1016/j.abb.2025.110668
Yuan Zhu , Sheng-an Su , Jixie Le , Yutao Xi , Meixiang Xiang

Background

The excessive deposition of extracellular matrix (ECM) components in cardiac tissue increases myocardial stiffness, contributing to diastolic dysfunction and arrhythmia risk. While this clinical association is established, the underlying electromechanical mechanisms remain elusive.

Methods

Using human and neonatal rat cardiomyocytes cultured on tunable 3D PDMS substrates replicating infarcted rat heart decellularized ECM (dECM) stiffness, we systematically investigated how ECM-mediated mechanical changes alter action potentials and sodium current dynamics, as well as Nav1.5 expression. 3D PDMS substrates were fabricated with stiffness values spanning the mechanical range of infarcted rat heart dECM (Young's modulus: ∼20–400 kPa; elastic modulus: ∼5–30 pN/nm). Human induced pluripotent stem cell-derived cardiomyocytes (15-day culture), neonatal rat cardiomyocytes (3-day culture) and human embryonic kidney 293 (24-h culture) cells stably expressing human Nav1.5 were cultured on the these PDMS substrates. Stiffness-dependent cellular electrophysiological effects were assessed using patch-clamp recordings. The gene and protein level changes were assessed by real-time quantitative polymerase chain reaction and immune blot.

Results

We found that evaluated substrate stiffness levels progressively reduced the AP upstroke slope, resulted in proarrhythmic AP morphologies characterized by increased AP instability and triangulation. Electrophysiological analysis revealed this mechanical modulation occurred through distinct sodium channel kinetic alterations: (1) a significant rightward-shifted voltage-dependent activation curve, and (2) a faster transition from a closed state to inactivation occurred, while maintaining unchanged current density, steady-state inactivation properties, and recovery time across stiffness conditions. This effect may arise from a conformation change in Nav1.5, since the expression and distribution of Nav1.5 has not altered across three PDMS groups.

Conclusions

In summary, substrate stiffening impaired cardiomyocyte depolarization and promoted conduction abnormalities via Nav1.5 dysfunction, suggesting a mechanoelectrical mechanism in ECM deposition related arrhythmogenesis.
背景:心肌组织中细胞外基质(ECM)成分的过度沉积会增加心肌硬度,导致舒张功能障碍和心律失常风险。虽然建立了这种临床联系,但潜在的机电机制仍然难以捉摸。方法:利用在可调3D PDMS基质上培养的人和新生大鼠心肌细胞复制梗死大鼠心脏脱细胞ECM (dECM)刚度,我们系统地研究了ECM介导的机械变化如何改变动作电位和钠电流动力学,以及Nav1.5的表达。三维PDMS基质的刚度值跨越梗死大鼠心脏dECM的力学范围(杨氏模量:~ 20-400 kPa;弹性模量:~ 5-30 pN/nm)。在这些PDMS基质上培养稳定表达人Nav1.5的人诱导多能干细胞来源的心肌细胞(培养15天)、新生大鼠心肌细胞(培养3天)和人胚胎肾293细胞(培养24小时)。使用膜片钳记录评估刚度依赖性细胞电生理效应。采用实时定量聚合酶链反应和免疫印迹法检测基因和蛋白水平变化。结果:我们发现评估的基底刚度水平逐渐降低了AP上冲程斜率,导致以AP不稳定性和三角化增加为特征的近心律失常AP形态。电生理分析表明,这种机械调节是通过不同的钠通道动力学改变发生的:(1)显著的向右移动的电压依赖激活曲线;(2)从闭合状态到失活的转变更快,同时保持不变的电流密度、稳态失活特性和恢复时间。这种影响可能是由Nav1.5的构象变化引起的,因为Nav1.5的表达和分布在三个PDMS组中没有改变。结论:综上所述,底物硬化损害心肌细胞去极化,并通过Nav1.5功能障碍促进传导异常,提示ECM沉积相关心律失常的机电机制。
{"title":"Substrate stiffness attenuates cardiomyocyte depolarization slope via sodium channel kinetics modulation","authors":"Yuan Zhu ,&nbsp;Sheng-an Su ,&nbsp;Jixie Le ,&nbsp;Yutao Xi ,&nbsp;Meixiang Xiang","doi":"10.1016/j.abb.2025.110668","DOIUrl":"10.1016/j.abb.2025.110668","url":null,"abstract":"<div><h3>Background</h3><div>The excessive deposition of extracellular matrix (ECM) components in cardiac tissue increases myocardial stiffness, contributing to diastolic dysfunction and arrhythmia risk. While this clinical association is established, the underlying electromechanical mechanisms remain elusive.</div></div><div><h3>Methods</h3><div>Using human and neonatal rat cardiomyocytes cultured on tunable 3D PDMS substrates replicating infarcted rat heart decellularized ECM (dECM) stiffness, we systematically investigated how ECM-mediated mechanical changes alter action potentials and sodium current dynamics, as well as Nav1.5 expression. 3D PDMS substrates were fabricated with stiffness values spanning the mechanical range of infarcted rat heart dECM (Young's modulus: ∼20–400 kPa; elastic modulus: ∼5–30 pN/nm). Human induced pluripotent stem cell-derived cardiomyocytes (15-day culture), neonatal rat cardiomyocytes (3-day culture) and human embryonic kidney 293 (24-h culture) cells stably expressing human Nav1.5 were cultured on the these PDMS substrates. Stiffness-dependent cellular electrophysiological effects were assessed using patch-clamp recordings. The gene and protein level changes were assessed by real-time quantitative polymerase chain reaction and immune blot.</div></div><div><h3>Results</h3><div>We found that evaluated substrate stiffness levels progressively reduced the AP upstroke slope, resulted in proarrhythmic AP morphologies characterized by increased AP instability and triangulation. Electrophysiological analysis revealed this mechanical modulation occurred through distinct sodium channel kinetic alterations: (1) a significant rightward-shifted voltage-dependent activation curve, and (2) a faster transition from a closed state to inactivation occurred, while maintaining unchanged current density, steady-state inactivation properties, and recovery time across stiffness conditions. This effect may arise from a conformation change in Nav1.5, since the expression and distribution of Nav1.5 has not altered across three PDMS groups.</div></div><div><h3>Conclusions</h3><div>In summary, substrate stiffening impaired cardiomyocyte depolarization and promoted conduction abnormalities via Nav1.5 dysfunction, suggesting a mechanoelectrical mechanism in ECM deposition related arrhythmogenesis.</div></div>","PeriodicalId":8174,"journal":{"name":"Archives of biochemistry and biophysics","volume":"775 ","pages":"Article 110668"},"PeriodicalIF":3.0,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145430219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SIRT7 deficiency promoted cuproptosis-mediated mitochondrial dysfunction and inhibited malignant development of cervical cancer SIRT7缺失促进铜裂介导的线粒体功能障碍,抑制宫颈癌的恶性发展。
IF 3 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-10-29 DOI: 10.1016/j.abb.2025.110651
Qun Gao , Qi Wang , Yanjiao Hu , Fangjie Xin , Jie Chen , Sha Yu , Xinli Chen , Qingqing Lv , Baoxia Cui , Jun Jiao , Xinlin Jiao

Purpose

To investigate the impact of SIRT7 on the development of cervical cancer and its relationship with cuproptosis in cervical cancer.

Method

HeLa and SiHa cells were transfected with lentiviruses for SIRT7 overexpression and knockdown. The effects of SIRT7 on cervical cancer cell proliferation, apoptosis, invasion, and migration were analyzed using CCK8, plate cloning, flow cytometry, Transwell assays, and scratch assays. To verify the relationship between SIRT7 and cuproptosis, we utilized cuproptosis inhibitors and activators. Immunofluorescence, transmission electron microscope, flow cytometry, ELISA, and Western blot were used to analyze copper ion content, mitochondrial ultrastructure, cellular reactive oxygen species, mitochondrial membrane potential, pyruvate levels, cell viability and the cuproptosis-related proteins.

Results

SIRT7 enhanced the proliferation, migration, and invasion of HeLa and SiHa cells, inhibited apoptosis, and promoted cervical cancer growth. Knocking down SIRT7 caused cuproptosis of HeLa and SiHa cells, characterized by increased Cu2+ content, disrupted mitochondrial structure, decreased membrane potential, elevated ROS production, and upregulation of cuproptosis-related proteins SLC31A1 and HSP70, and downregulation of FDX1, LIAS and DLAT. Low SIRT7 expression's effect on cuproptosis was reduced by TTM. SIRT7 overexpression inhibited cuproptosis, unlike SIRT7 knockdown. SIRT7 overexpression's inhibitory effect on cuproptosis is altered by rhSLC31A1.

Conclusion

SIRT7 was recognized as an oncogene in cervical cancer, which boosted cervical cancer cell proliferation and invasion, lowered intracellular copper levels, and prevented cuproptosis. SIRT7 downregulation triggered cuproptosis, inhibiting tumor cell growth.
目的:探讨SIRT7对宫颈癌发生发展的影响及其与宫颈癌铜体畸形的关系。方法:用慢病毒转染Hela和SiHa细胞,进行SIRT7过表达和敲低。采用CCK8、平板克隆、流式细胞术、Transwell实验和划痕实验分析SIRT7对宫颈癌细胞增殖、凋亡、侵袭和迁移的影响。为了验证SIRT7与铜突起之间的关系,我们使用了铜突起抑制剂和活化剂。采用免疫荧光、透射电镜、流式细胞术、酶联免疫吸附法、免疫印迹法等检测各组铜离子含量、线粒体超微结构、细胞活性氧、线粒体膜电位、丙酮酸水平、细胞活力及铜脱落相关蛋白。结果:SIRT7增强HeLa和SiHa细胞的增殖、迁移和侵袭,抑制凋亡,抑制宫颈癌生长。敲除SIRT7导致HeLa和SiHa细胞铜变形,其特征是Cu2+含量增加,线粒体结构破坏,膜电位降低,ROS生成增加,铜变形蛋白SLC31A1和HSP70上调,FDX1、LIAS和DLAT下调。SIRT7低表达对铜生长的影响被TTM降低。与SIRT7敲低不同,SIRT7过表达抑制铜突起。SIRT7过表达对铜生长的抑制作用被rhSLC31A1改变。结论:SIRT7在宫颈癌中被认为是一种致癌基因,可促进宫颈癌细胞的增殖和侵袭,降低细胞内铜水平,防止铜沉降。SIRT7下调触发cuprotosis,抑制肿瘤细胞生长。
{"title":"SIRT7 deficiency promoted cuproptosis-mediated mitochondrial dysfunction and inhibited malignant development of cervical cancer","authors":"Qun Gao ,&nbsp;Qi Wang ,&nbsp;Yanjiao Hu ,&nbsp;Fangjie Xin ,&nbsp;Jie Chen ,&nbsp;Sha Yu ,&nbsp;Xinli Chen ,&nbsp;Qingqing Lv ,&nbsp;Baoxia Cui ,&nbsp;Jun Jiao ,&nbsp;Xinlin Jiao","doi":"10.1016/j.abb.2025.110651","DOIUrl":"10.1016/j.abb.2025.110651","url":null,"abstract":"<div><h3>Purpose</h3><div>To investigate the impact of SIRT7 on the development of cervical cancer and its relationship with cuproptosis in cervical cancer.</div></div><div><h3>Method</h3><div>HeLa and SiHa cells were transfected with lentiviruses for SIRT7 overexpression and knockdown. The effects of SIRT7 on cervical cancer cell proliferation, apoptosis, invasion, and migration were analyzed using CCK8, plate cloning, flow cytometry, Transwell assays, and scratch assays. To verify the relationship between SIRT7 and cuproptosis, we utilized cuproptosis inhibitors and activators. Immunofluorescence, transmission electron microscope, flow cytometry, ELISA, and Western blot were used to analyze copper ion content, mitochondrial ultrastructure, cellular reactive oxygen species, mitochondrial membrane potential, pyruvate levels, cell viability and the cuproptosis-related proteins.</div></div><div><h3>Results</h3><div>SIRT7 enhanced the proliferation, migration, and invasion of HeLa and SiHa cells, inhibited apoptosis, and promoted cervical cancer growth. Knocking down SIRT7 caused cuproptosis of HeLa and SiHa cells, characterized by increased Cu<sup>2+</sup> content, disrupted mitochondrial structure, decreased membrane potential, elevated ROS production, and upregulation of cuproptosis-related proteins SLC31A1 and HSP70, and downregulation of FDX1, LIAS and DLAT. Low SIRT7 expression's effect on cuproptosis was reduced by TTM. SIRT7 overexpression inhibited cuproptosis, unlike SIRT7 knockdown. SIRT7 overexpression's inhibitory effect on cuproptosis is altered by rhSLC31A1.</div></div><div><h3>Conclusion</h3><div>SIRT7 was recognized as an oncogene in cervical cancer, which boosted cervical cancer cell proliferation and invasion, lowered intracellular copper levels, and prevented cuproptosis. SIRT7 downregulation triggered cuproptosis, inhibiting tumor cell growth.</div></div>","PeriodicalId":8174,"journal":{"name":"Archives of biochemistry and biophysics","volume":"775 ","pages":"Article 110651"},"PeriodicalIF":3.0,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145407881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma” [Arch. Biochem. Biophys. 754 (2024) 109929] “在弥漫性大B细胞淋巴瘤中,双氢celastrol通过BCR/AP-1/junb信号诱导细胞死亡并抑制血管生成”的更正[Arch。物化学。生物工程学报,2016,32(2):389 - 389。
IF 3 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-10-29 DOI: 10.1016/j.abb.2025.110652
Yue Lai , Shushan Guo , Qiongwei Tang , Gaomei Chang , Hui Zhang , Bo Li , Qilin Feng , Ke Hu , Zhijian Xu , Xuejie Gao , Qikai Zhang , Hongfei Yi , Dongliang Song , Yifei Zhang , Yu Peng , Haiyan Cai , Weiliang Zhu , Jumei Shi
{"title":"Corrigendum to “Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma” [Arch. Biochem. Biophys. 754 (2024) 109929]","authors":"Yue Lai ,&nbsp;Shushan Guo ,&nbsp;Qiongwei Tang ,&nbsp;Gaomei Chang ,&nbsp;Hui Zhang ,&nbsp;Bo Li ,&nbsp;Qilin Feng ,&nbsp;Ke Hu ,&nbsp;Zhijian Xu ,&nbsp;Xuejie Gao ,&nbsp;Qikai Zhang ,&nbsp;Hongfei Yi ,&nbsp;Dongliang Song ,&nbsp;Yifei Zhang ,&nbsp;Yu Peng ,&nbsp;Haiyan Cai ,&nbsp;Weiliang Zhu ,&nbsp;Jumei Shi","doi":"10.1016/j.abb.2025.110652","DOIUrl":"10.1016/j.abb.2025.110652","url":null,"abstract":"","PeriodicalId":8174,"journal":{"name":"Archives of biochemistry and biophysics","volume":"776 ","pages":"Article 110652"},"PeriodicalIF":3.0,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145399652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CXCL17 activates three MAS-related G protein-coupled receptors independently of its conserved C-terminal fragment CXCL17独立于其保守的c端片段激活三个mas相关的G蛋白偶联受体。
IF 3 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-10-28 DOI: 10.1016/j.abb.2025.110666
Wen-Feng Hu, Juan-Juan Wang, Jie Yu, Ya-Li Liu, Zeng-Guang Xu, Zhan-Yun Guo
C-X-C motif chemokine ligand 17 (CXCL17) is a chemoattractant whose receptor remains controversial. While recent studies identified CXCL17 as an agonist of G protein-coupled receptor 25 (GPR25), it was also reported to activate MAS-related GPR family member X2 (MRGPRX2), a member of MAS-related G protein-coupled receptors (MRGPRs), though this finding has not yet been reproduced by other laboratories. In this study, we confirmed that micromolar concentrations of human CXCL17 activate human MRGPRX2 in transfected human embryonic kidney (HEK) 293T cells using a NanoLuc Binary Technology (NanoBiT)-based β-arrestin recruitment assay. We further demonstrated that human CXCL17 also activates MRGPRX1 and MAS1 among 10 human MRGPRs in the same assay. CXCL17 could also induce chemotactic movement of transfected HEK293T cells expressing MRGPRX2, MRGPRX1, or MAS1. However, removal of C-terminal residues from CXCL17 did not affect its activation of these three MRGPRs, even though this region is essential for GPR25 activation. These results suggest that CXCL17 activates MRGPRX2, MRGPRX1, and MAS1 through a mechanism distinct from GPR25 activation. Further investigation is needed to determine whether these MRGPRs mediate the in vivo functions of CXCL17.
C-X-C基序趋化因子配体17 (CXCL17)是一种化学引诱剂,其受体仍存在争议。虽然最近的研究发现CXCL17是G蛋白偶联受体25 (GPR25)的激动剂,但也有报道称它可以激活mas相关GPR家族成员X2 (MRGPRX2),这是mas相关G蛋白偶联受体(MRGPRs)的成员,尽管这一发现尚未被其他实验室复制。在这项研究中,我们使用NanoLuc Binary Technology (NanoBiT)为基础的β-阻滞蛋白募集实验,证实了微摩尔浓度的人CXCL17在转染的人胚胎肾(HEK) 293T细胞中激活人MRGPRX2。在相同的实验中,我们进一步证明了人类CXCL17也激活了10个人类mrgpr中的MRGPRX1和MAS1。CXCL17还能诱导表达MRGPRX2、MRGPRX1或MAS1的转染HEK293T细胞的趋化运动。然而,从CXCL17中去除c端残基并不影响其对这三种mrgpr的激活,尽管该区域对GPR25的激活至关重要。这些结果表明,CXCL17激活MRGPRX2、MRGPRX1和MAS1的机制与GPR25的激活机制不同。需要进一步的研究来确定这些MRGPRs是否介导CXCL17的体内功能。
{"title":"CXCL17 activates three MAS-related G protein-coupled receptors independently of its conserved C-terminal fragment","authors":"Wen-Feng Hu,&nbsp;Juan-Juan Wang,&nbsp;Jie Yu,&nbsp;Ya-Li Liu,&nbsp;Zeng-Guang Xu,&nbsp;Zhan-Yun Guo","doi":"10.1016/j.abb.2025.110666","DOIUrl":"10.1016/j.abb.2025.110666","url":null,"abstract":"<div><div>C-X-C motif chemokine ligand 17 (CXCL17) is a chemoattractant whose receptor remains controversial. While recent studies identified CXCL17 as an agonist of G protein-coupled receptor 25 (GPR25), it was also reported to activate MAS-related GPR family member X2 (MRGPRX2), a member of MAS-related G protein-coupled receptors (MRGPRs), though this finding has not yet been reproduced by other laboratories. In this study, we confirmed that micromolar concentrations of human CXCL17 activate human MRGPRX2 in transfected human embryonic kidney (HEK) 293T cells using a NanoLuc Binary Technology (NanoBiT)-based β-arrestin recruitment assay. We further demonstrated that human CXCL17 also activates MRGPRX1 and MAS1 among 10 human MRGPRs in the same assay. CXCL17 could also induce chemotactic movement of transfected HEK293T cells expressing MRGPRX2, MRGPRX1, or MAS1. However, removal of C-terminal residues from CXCL17 did not affect its activation of these three MRGPRs, even though this region is essential for GPR25 activation. These results suggest that CXCL17 activates MRGPRX2, MRGPRX1, and MAS1 through a mechanism distinct from GPR25 activation. Further investigation is needed to determine whether these MRGPRs mediate the <em>in vivo</em> functions of CXCL17.</div></div>","PeriodicalId":8174,"journal":{"name":"Archives of biochemistry and biophysics","volume":"775 ","pages":"Article 110666"},"PeriodicalIF":3.0,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145407900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical value of serum miR-943 as a diagnostic and prognostic biomarker for acute cerebral infarction and its mechanism of action via targeting BDNF 血清miR-943作为急性脑梗死诊断和预后生物标志物的临床价值及其靶向BDNF的作用机制
IF 3 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-10-28 DOI: 10.1016/j.abb.2025.110667
Sheng Lin, Junbin Chen

Background

Dysregulated microRNAs are implicated in the acute cerebral infarction (ACI) pathogenesis.

Aim

This study investigated the clinical significance and mechanisms of miR-943 in ACI.

Methods

Serum miR-943 levels were measured using RT-qPCR in 132 ACI patients and 135 healthy controls (HC). Diagnostic potential was evaluated by ROC analysis. Prognosis was assessed using 90-day mRS scores. Correlations with clinical parameters were analyzed using Pearson's/Spearman's tests. Multivariate logistic regression identified outcome predictors. Bioinformatic prediction and experimental validation (dual-luciferase, RIP assays) identified miR-943 targets. An OGD/R model in BV-2 microglia simulated ischemia-reperfusion. Effects of miR-943 inhibitors and si-BDNF on viability (CCK-8), apoptosis (flow cytometry), and inflammation (ELISA) were assessed.

Results

ACI patients exhibited significantly elevated serum miR-943 expression and reduced BDNF levels versus HC. miR-943 showed high diagnostic value (AUC = 0.909, sensitivity 85.6 %, specificity 83.7 %). MiR-943 expression correlated positively with SBP, DBP, FBG, Hcy, NIHSS score, and infarct volume. Patients with a poor prognosis exhibited significantly higher miR-943 expression levels. Multivariate analysis identified high expression of miR-943 as an independent risk factor for poor outcome. BDNF was validated as a direct miR-943 target gene. OGD/R increased miR-943 expression, suppressed proliferation, promoted apoptosis, and enhanced the expression of inflammatory factors in BV-2 cells. Inhibiting miR-943 expression reversed these detrimental effects, enhancing proliferation and reducing apoptosis/inflammation. Critically, BDNF knockdown abolished the protective effects of miR-943 inhibition.

Conclusion

Serum miR-943 is a promising diagnostic and prognostic biomarker for ACI. It exerts pathological effects by post-transcriptionally suppressing BDNF. Targeting the miR-943/BDNF axis represents a potential therapeutic strategy.
背景:microrna失调与急性脑梗死(ACI)的发病机制有关。目的:探讨miR-943在ACI中的临床意义及机制。方法:采用RT-qPCR检测132例ACI患者和135例健康对照(HC)的血清miR-943水平。采用ROC分析评估诊断潜力。采用90天mRS评分评估预后。使用Pearson’s/Spearman’s检验分析与临床参数的相关性。多变量逻辑回归确定了结果预测因子。生物信息学预测和实验验证(双荧光素酶,RIP测定)确定了miR-943靶点。BV-2小胶质细胞OGD/R模型模拟缺血再灌注。评估miR-943抑制剂和si-BDNF对细胞活力(CCK-8)、细胞凋亡(流式细胞术)和炎症(ELISA)的影响。结果:与HC相比,ACI患者血清miR-943表达显著升高,BDNF水平显著降低。miR-943具有较高的诊断价值(AUC=0.909,敏感性85.6%,特异性83.7%)。MiR-943的表达与收缩压、舒张压、空腹血糖、Hcy、NIHSS评分和梗死体积呈正相关。预后较差的患者miR-943表达水平明显升高。多因素分析发现miR-943的高表达是不良预后的独立危险因素。BDNF被证实是miR-943的直接靶基因。OGD/R增加BV-2细胞中miR-943的表达,抑制细胞增殖,促进细胞凋亡,增强炎症因子的表达。抑制miR-943的表达逆转了这些不利影响,增强了细胞增殖,减少了细胞凋亡/炎症。关键的是,BDNF敲低消除了miR-943抑制的保护作用。结论:血清miR-943是一种有前景的ACI诊断和预后生物标志物。它通过转录后抑制BDNF发挥病理作用。靶向miR-943/BDNF轴代表了一种潜在的治疗策略。
{"title":"Clinical value of serum miR-943 as a diagnostic and prognostic biomarker for acute cerebral infarction and its mechanism of action via targeting BDNF","authors":"Sheng Lin,&nbsp;Junbin Chen","doi":"10.1016/j.abb.2025.110667","DOIUrl":"10.1016/j.abb.2025.110667","url":null,"abstract":"<div><h3>Background</h3><div>Dysregulated microRNAs are implicated in the acute cerebral infarction (ACI) pathogenesis.</div></div><div><h3>Aim</h3><div>This study investigated the clinical significance and mechanisms of miR-943 in ACI.</div></div><div><h3>Methods</h3><div>Serum miR-943 levels were measured using RT-qPCR in 132 ACI patients and 135 healthy controls (HC). Diagnostic potential was evaluated by ROC analysis. Prognosis was assessed using 90-day mRS scores. Correlations with clinical parameters were analyzed using Pearson's/Spearman's tests. Multivariate logistic regression identified outcome predictors. Bioinformatic prediction and experimental validation (dual-luciferase, RIP assays) identified miR-943 targets. An OGD/R model in BV-2 microglia simulated ischemia-reperfusion. Effects of miR-943 inhibitors and si-BDNF on viability (CCK-8), apoptosis (flow cytometry), and inflammation (ELISA) were assessed.</div></div><div><h3>Results</h3><div>ACI patients exhibited significantly elevated serum miR-943 expression and reduced BDNF levels versus HC. miR-943 showed high diagnostic value (AUC = 0.909, sensitivity 85.6 %, specificity 83.7 %). MiR-943 expression correlated positively with SBP, DBP, FBG, Hcy, NIHSS score, and infarct volume. Patients with a poor prognosis exhibited significantly higher miR-943 expression levels. Multivariate analysis identified high expression of miR-943 as an independent risk factor for poor outcome. BDNF was validated as a direct miR-943 target gene. OGD/R increased miR-943 expression, suppressed proliferation, promoted apoptosis, and enhanced the expression of inflammatory factors in BV-2 cells. Inhibiting miR-943 expression reversed these detrimental effects, enhancing proliferation and reducing apoptosis/inflammation. Critically, BDNF knockdown abolished the protective effects of miR-943 inhibition.</div></div><div><h3>Conclusion</h3><div>Serum miR-943 is a promising diagnostic and prognostic biomarker for ACI. It exerts pathological effects by post-transcriptionally suppressing BDNF. Targeting the miR-943/BDNF axis represents a potential therapeutic strategy.</div></div>","PeriodicalId":8174,"journal":{"name":"Archives of biochemistry and biophysics","volume":"775 ","pages":"Article 110667"},"PeriodicalIF":3.0,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145407760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archives of biochemistry and biophysics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1